Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...

The Joint Commission’s new National Performance Goals take effect in January 2026 and language access, once viewed as a patient experience issue, is emerging as a core safety and accreditation ...

Hundreds of people queued for food assistance at a central Texas high school on Saturday, November 1, as millions across America lost access to the Supplemental Nutrition Assistance Program (SNAP).

A Kenyan entrepreneur who designed an app that translates speech into sign language using AI-powered 3D avatars has won a major award for African innovation. “Think of it as Google Translate for sign ...

While Python continues to be the runaway leader in Tiobe’s monthly index of programming language popularity, C, C++, and Java are engaged in a fierce battle for second place. Currently in fifth place, ...

The Justice Department is investigating whether Washington, D.C., police manipulated data to make crime rates appear lower, two senior law enforcement officials confirmed to NBC News. The ...

Samsung C&T and Vietnam’s CMC Corp. are investing $1.3 billion to build a data center hub in Ho Chi Minh City to tap into the growing demand for cloud computing and AI in the country. The project will ...